226 related articles for article (PubMed ID: 11038265)
41. Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults.
Fedson DS; Liss C
Vaccine; 2004 Feb; 22(8):927-46. PubMed ID: 15161070
[TBL] [Abstract][Full Text] [Related]
42. Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against all respiratory tract infections in children under two years of age.
Karppinen S; Toivonen L; Schuez-Havupalo L; Teros-Jaakkola T; Waris M; Auranen K; Palmu AA; Peltola V
Vaccine; 2019 May; 37(22):2935-2941. PubMed ID: 31027929
[TBL] [Abstract][Full Text] [Related]
43. Pneumococcal vaccines for children and adults with bronchiectasis.
Chang CC; Singleton RJ; Morris PS; Chang AB
Cochrane Database Syst Rev; 2009 Apr; 2009(2):CD006316. PubMed ID: 19370631
[TBL] [Abstract][Full Text] [Related]
44. Pneumococcal polysaccharide vaccine: a systematic review of clinical effectiveness in adults.
Watson L; Wilson BJ; Waugh N
Vaccine; 2002 May; 20(17-18):2166-73. PubMed ID: 12009269
[TBL] [Abstract][Full Text] [Related]
45. [Pneumococcal vaccine effectiveness in the elderly. Systematic review and meta-analysis].
Puig-Barberà J; Belenguer Varea A; Goterris Pinto M; Brines Benlliure MJ
Aten Primaria; 2002 Sep; 30(5):269-81; discussion 281-3. PubMed ID: 12372207
[TBL] [Abstract][Full Text] [Related]
46. Pneumococcal vaccine in the prevention of community-acquired pneumonia: a skeptical view of cost-effectiveness.
Simberkoff MS
Semin Respir Infect; 1993 Dec; 8(4):294-9. PubMed ID: 7938926
[TBL] [Abstract][Full Text] [Related]
47. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial.
Cutts FT; Zaman SM; Enwere G; Jaffar S; Levine OS; Okoko JB; Oluwalana C; Vaughan A; Obaro SK; Leach A; McAdam KP; Biney E; Saaka M; Onwuchekwa U; Yallop F; Pierce NF; Greenwood BM; Adegbola RA;
Lancet; 2005 Mar 26-Apr 1; 365(9465):1139-46. PubMed ID: 15794968
[TBL] [Abstract][Full Text] [Related]
48. Effectiveness and safety of dual influenza and pneumococcal vaccination versus separate administration or no vaccination in older adults: a meta-analysis.
Yin M; Huang L; Zhang Y; Yu N; Xu X; Liang Y; Ni J
Expert Rev Vaccines; 2018 Jul; 17(7):653-663. PubMed ID: 29961353
[TBL] [Abstract][Full Text] [Related]
49. Pneumococcal vaccination for the elderly in The Netherlands? Assessment of the quality and content of available comparative studies.
Assendelf WJ; Scholten RJ; Offringa M
Neth J Med; 2004 Feb; 62(2):36-44. PubMed ID: 15127829
[TBL] [Abstract][Full Text] [Related]
50. Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease.
Walters JA; Smith S; Poole P; Granger RH; Wood-Baker R
Cochrane Database Syst Rev; 2010 Nov; (11):CD001390. PubMed ID: 21069668
[TBL] [Abstract][Full Text] [Related]
51. [Prevention of Streptococcus pneumoniae (pneumococcal) infections in adults].
Ludwig E; Mészner Z;
Orv Hetil; 2014 Dec; 155(50):1996-2004. PubMed ID: 25481502
[TBL] [Abstract][Full Text] [Related]
52. Adult pneumococcal vaccination guideline. SAMA-SA Pulmonology Society Working Group.
S Afr Med J; 1999 Nov; 89(11 Suppl):1222-30. PubMed ID: 10599303
[TBL] [Abstract][Full Text] [Related]
53. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
54. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.
Bonten MJ; Huijts SM; Bolkenbaas M; Webber C; Patterson S; Gault S; van Werkhoven CH; van Deursen AM; Sanders EA; Verheij TJ; Patton M; McDonough A; Moradoghli-Haftvani A; Smith H; Mellelieu T; Pride MW; Crowther G; Schmoele-Thoma B; Scott DA; Jansen KU; Lobatto R; Oosterman B; Visser N; Caspers E; Smorenburg A; Emini EA; Gruber WC; Grobbee DE
N Engl J Med; 2015 Mar; 372(12):1114-25. PubMed ID: 25785969
[TBL] [Abstract][Full Text] [Related]
55. Influenza vaccines in immunosuppressed adults with cancer.
Bitterman R; Eliakim-Raz N; Vinograd I; Zalmanovici Trestioreanu A; Leibovici L; Paul M
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD008983. PubMed ID: 29388675
[TBL] [Abstract][Full Text] [Related]
56. Community-Acquired Pneumococcal Pneumonia in Highly Vaccinated Population: Analysis by Serotypes, Vaccination Status, and Underlying Medical Conditions.
Hyun H; Jang AY; Suh JW; Bae IG; Choi WS; Seo YB; Lee J; Yoon JG; Noh JY; Cheong HJ; Kim WJ; Kim MJ; Song JY
J Korean Med Sci; 2023 Oct; 38(42):e330. PubMed ID: 37904655
[TBL] [Abstract][Full Text] [Related]
57. Pneumococcal conjugate vaccines for preventing otitis media.
Fortanier AC; Venekamp RP; Boonacker CW; Hak E; Schilder AG; Sanders EA; Damoiseaux RA
Cochrane Database Syst Rev; 2014 Apr; (4):CD001480. PubMed ID: 24696098
[TBL] [Abstract][Full Text] [Related]
58. Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain.
Domínguez À; Soldevila N; Toledo D; Torner N; Force L; Pérez MJ; Martín V; Rodríguez-Rojas L; Astray J; Egurrola M; Sanz F; Castilla J;
PLoS One; 2017; 12(2):e0171943. PubMed ID: 28187206
[TBL] [Abstract][Full Text] [Related]
59. [Vaccinal Prevention of Lower Respiratory Tract Pneumococcal Disease in Adults Without Immunosuppression.].
Guchev IA
Antibiot Khimioter; 2016; 61(7-8):48-57. PubMed ID: 29533560
[TBL] [Abstract][Full Text] [Related]
60. Streptococcus pneumoniae vaccination in older adults.
Rightmier E; Stevens V; Brown J
Am J Geriatr Pharmacother; 2011 Dec; 9(6):392-404. PubMed ID: 22047941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
